Top Market Shifts Transforming the Tissue Microarray Market Landscape: Key Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Tissue Microarray Market Through 2025?
Significant growth has been observed in the tissue microarray market in recent years. The market, which was valued at $12.05 billion in 2024, is projected to expand to $13.11 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.8%. Key factors driving this growth during the historical period include an increase in precision medicine, advances in drug discovery and development, improved efficiency in analysis, a rise in chronic disease prevalence and expanded biobanking initiatives.

What's the Projected Size of the Global Tissue Microarray Market by 2029?
The market size of tissue microarray is projected to experience swift expansion in the coming years, expecting to reach $20.85 billion by 2029 with a compound annual growth rate (CAGR) of 12.3%. Factors contributing to this growth during the forecast period include the rise of digital pathology, expanded usage, a thriving biopharmaceutical sector, regulatory backing and standards, as well as the incorporation of AI and machine learning. Key trends to look out for during this forecast period comprise enhancements in imaging technologies, the production of 3d tissue microarrays, high-content screening, standardization efforts, and the inclusion of single-cell analysis.

View the full report here:
https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

Top Growth Drivers in the Tissue Microarray Industry: What's Accelerating the Market?
The escalating incidence of cancer is predicted to push the expansion of the tissue microarray market. Cancer encompasses a range of diseases which occur when abnormal cells multiply uncontrollably, cross their normal limits and either metastasize to other parts or invade nearby organs or tissues. Tissue microarrays play a key role in oncology for examining the expression of cancer-related biomarkers in different tumor specimens. For instance, Macmillan Cancer Support, a cancer charity based in the UK, revealed in June 2022 that the count of cancer patients had touched 3 million in 2022, with expectations to rise close to 3.5 million by 2025 and hit 4 million by 2030 in the UK. This escalating incidence of cancer is thus propelling the expansion of the tissue microarray market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

Which Emerging Trends Are Transforming the Tissue Microarray Market in 2025?
There is a rising trend of strategic alliances in the tissue microarray market, as large corporations collaborate to innovate and enhance tissue microarray technologies. For example, in November 2022, The Cureline Group, a US American company delivering translational and precision medicine CRO, joined forces with Cellecta Inc., an American provider of RNAi and CRISPR screening products. Their collaboration, known as Tissue 2 Target Services, aims to merge the expertise of both companies in cell and tissue molecular analysis with human biospecimen management. This is done to provide facilities that focus on pre-clinical and translational research with streamlined workflows for gene target and biomarker discovery services. Also, in September 2022, Ultivue Inc., a US-based biotech firm that formulates reagent-based solutions to optimize information from cell and tissue specimens, collaborated with the ngTMA, a Switzerland-based Translational Research Unit platform by the University of Bern focused on developing innovative tissue microarray construction workflows. The intention of this collaboration is to push forward multiplexed immunofluorescence (mIF) assays and leverage fresh TMA technologies to facilitate spatial analysis in scientific studies and elevate the standard of TMAs employed in clinical and translational research.

What Are the Main Segments in the Tissue Microarray Market?
The tissue microarray market covered in this report is segmented -

1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types
2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting
3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics
4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals

Subsegments:
1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry
2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH
3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array
4) By Other Types: Nucleic Acid Microarrays, RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12236&type=smp

Which Top Companies are Driving Growth in the Tissue Microarray Market?
Major companies operating in the tissue microarray market include Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, dic*kinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

Which Regions Will Dominate the Tissue Microarray Market Through 2029?
North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12236

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.